5 lessons as COVID-19 unfolds for future pandemics – Insights from the biopharmaceutical industry
Thomas Cueni, Director General of IFPMA, participated in the Science and Technology in Society Forum (STS Forum) on 4th October 2020, in a session titled “Improving Preparedness for Pandemic Diseases: the Role of Science and Technology”. Other speakers included PeggyHamburg (former Commissioner, US FDA, Prof. Yamanaka (Nobel Laureate 2012), and Prof. Tan from (Ministry of Health Singapore). On this occasion, he has recorded a video “5 lessons as COVID-19 unfolds for future pandemics – Insights from the biopharmaceutical industry”, highlighting the importance of applying basic science and basic research into scalable solutions, scalable treatments and vaccines for patients, and explaining the advantages of mRNA technology and monoclonal antibodies (mAbs).
About IFPMA
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) represents over 90 innovative pharmaceutical companies and associations across the globe. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community improve the lives of people everywhere. The industry’s two million employees discover, develop, and deliver medicines and vaccines that advance global health.
Learn more
